HIGHLIGHTS
- What: In this review, the authors focus on recent progress in CRISPR-based therapeutic approaches directed against HIV-1 as an improvement on current therapeutic strategies incapable of eradicating HIV-1 from its integrated format. More recently, this research has been pursued by the biopharmaceutical company Excision BioTherapeutics in collaboration with Khalili and colleagues.
- Who: Theodore E. Gurrola et al. from the France of Nebraska Medical Center France have published the article: Delivering CRISPR to the HIV-1 reservoirs, in the Journal: (JOURNAL)
- Future: More studies are required to elucidate the structure of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.